| LDR | | 00000nam u2200205 4500 |
| 001 | | 000000435119 |
| 005 | | 20200227115118 |
| 008 | | 200131s2018 ||||||||||||||||| ||eng d |
| 020 | |
▼a 9781687950062 |
| 035 | |
▼a (MiAaPQ)AAI27539187 |
| 035 | |
▼a (MiAaPQ)OhioLINKosu1531790292235549 |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 247004 |
| 082 | 0 |
▼a 362.1 |
| 100 | 1 |
▼a Cramer, Megan Louise. |
| 245 | 10 |
▼a Novel signaling pathways in skeletal muscle: Modifiers of disease and the immune response to therapies. |
| 260 | |
▼a [S.l.]:
▼b The Ohio State University.,
▼c 2018. |
| 260 | 1 |
▼a Ann Arbor:
▼b ProQuest Dissertations & Theses,
▼c 2018. |
| 300 | |
▼a 181 p. |
| 500 | |
▼a Source: Dissertations Abstracts International, Volume: 81-06, Section: B. |
| 500 | |
▼a Advisor: Martin, Paul T. |
| 502 | 1 |
▼a Thesis (Ph.D.)--The Ohio State University, 2018. |
| 506 | |
▼a This item must not be sold to any third party vendors. |
| 520 | |
▼a Duchenne muscular dystrophy (DMD) is a recessive X-linked childhood myopathy that is caused by a loss of dystrophin protein expression in cardiac and skeletal muscles. DMD patients develop profound skeletal muscle wasting with pronounced muscle weakness, often associated with eventual loss of cardiac and/or respiratory function. No effective treatment yet exists |
| 590 | |
▼a School code: 0168. |
| 650 | 4 |
▼a Immunology. |
| 650 | 4 |
▼a Molecular biology. |
| 650 | 4 |
▼a Physiology. |
| 650 | 4 |
▼a Health sciences. |
| 650 | 4 |
▼a Epidemiology. |
| 650 | 4 |
▼a Health care management. |
| 690 | |
▼a 0982 |
| 690 | |
▼a 0307 |
| 690 | |
▼a 0566 |
| 690 | |
▼a 0766 |
| 690 | |
▼a 0769 |
| 690 | |
▼a 0719 |
| 710 | 20 |
▼a The Ohio State University.
▼b Molecular, Cellular and Developmental Biology. |
| 773 | 0 |
▼t Dissertations Abstracts International
▼g 81-06B. |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 0168 |
| 791 | |
▼a Ph.D. |
| 792 | |
▼a 2018 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T15494336
▼n KERIS
▼z 이 자료의 원문은 한국교육학술정보원에서 제공합니다. |
| 980 | |
▼a 202002
▼f 2020 |
| 990 | |
▼a ***1008102 |
| 991 | |
▼a E-BOOK |